These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Patients eligible for modulator drugs: Data from cystic fibrosis registry of Turkey. Çobanoğlu N; Özçelik U; Çakır E; Şişmanlar Eyüboğlu T; Pekcan S; Cinel G; Yalçın E; Kiper N; Emiralioğlu N; Şen V; Şen HS; Ercan Ö; Çokuğraş H; Kılınç AA; Al Shadfan LM; Yazan H; Altıntaş DU; Karagöz D; Demir E; Kartal Öztürk G; Bingöl A; Başaran AE; Sapan N; Çekiç Ş; Çelebioğlu E; Aslan AT; Gürsoy TR; Tuğcu G; Özdemir A; Harmancı K; Yıldırım GK; Köse M; Hangül M; Tamay Z; Süleyman A; Yüksel H; Yılmaz Ö; Özcan G; Topal E; Can D; Korkmaz Ekren P; Çaltepe G; Kılıç M; Özdoğan Ş; Doğru D Pediatr Pulmonol; 2020 Sep; 55(9):2302-2306. PubMed ID: 32453906 [TBL] [Abstract][Full Text] [Related]
43. The frequency of the delta F508 mutation in the cystic fibrosis genes of 71 unrelated South African cystic fibrosis patients. Herbert JS; Retief AE S Afr Med J; 1992 Jul; 82(1):13-5. PubMed ID: 1641711 [TBL] [Abstract][Full Text] [Related]
45. A New Era for Cystic Fibrosis and Cystic Fibrosis Transmembrane Conductance Regulator Modulator Trials in Infants. Wainwright CE Am J Respir Crit Care Med; 2022 Nov; 206(10):1193-1195. PubMed ID: 35856818 [No Abstract] [Full Text] [Related]
46. Targeting the basic defect in cystic fibrosis. Welsh MJ N Engl J Med; 2010 Nov; 363(21):2056-7. PubMed ID: 21083391 [No Abstract] [Full Text] [Related]
50. New drug treatments for cystic fibrosis. Smyth RL BMJ; 2020 Jan; 368():m118. PubMed ID: 31959620 [No Abstract] [Full Text] [Related]
51. A lesson in participatory research for a rare mutation of cystic fibrosis. Kramer-Golinkoff E J Gen Intern Med; 2014 Aug; 29 Suppl 3(Suppl 3):S808-9. PubMed ID: 25029983 [No Abstract] [Full Text] [Related]
52. A combination therapy for cystic fibrosis. Brodsky JL; Frizzell RA Cell; 2015 Sep; 163(1):17. PubMed ID: 26406363 [TBL] [Abstract][Full Text] [Related]
53. Rescuing protein conformation: prospects for pharmacological therapy in cystic fibrosis. Gelman MS; Kopito RR J Clin Invest; 2002 Dec; 110(11):1591-7. PubMed ID: 12464661 [No Abstract] [Full Text] [Related]
54. Gentamicin in pharmacogenetic approach to treatment of cystic fibrosis. Hamilton JW Lancet; 2001 Dec; 358(9298):2014-6. PubMed ID: 11755605 [No Abstract] [Full Text] [Related]
55. Amiloride for lung disease in cystic fibrosis. Zahaykevich A DICP; 1991 Dec; 25(12):1340-1. PubMed ID: 1815431 [No Abstract] [Full Text] [Related]
56. Cystic fibrosis: CFTR modulators and their mechanism of action. Nieddu E Curr Pharm Des; 2013; 19(19):3474-5. PubMed ID: 23331031 [No Abstract] [Full Text] [Related]